Document is current
Any future updates will be listed below
-
Authors
Banu, Matei A https://orcid.org/0000-0003-2330-1810
Dovas, Athanassios
Argenziano, Michael G
Zhao, Wenting https://orcid.org/0000-0002-5927-2006
Sperring, Colin P
Cuervo Grajal, Henar https://orcid.org/0000-0001-8293-9377
Liu, Zhouzerui
Higgins, Dominique MO
Amini, Misha
Pereira, Brianna
Ye, Ling F
Mahajan, Aayushi
Humala, Nelson
Furnari, Julia L
Upadhyayula, Pavan S
Zandkarimi, Fereshteh
Nguyen, Trang TT https://orcid.org/0000-0001-8747-9082
Teasley, Damian
Wu, Peter B
Hai, Li
Karan, Charles
Dowdy, Tyrone
Razavilar, Aida
Siegelin, Markus D https://orcid.org/0000-0001-7113-3634
Kitajewski, Jan
Larion, Mioara https://orcid.org/0000-0002-7016-9587
Bruce, Jeffrey N https://orcid.org/0000-0002-6844-0286
Stockwell, Brent R https://orcid.org/0000-0002-3532-3868
Sims, Peter A https://orcid.org/0000-0002-3921-4837
Canoll, Peter https://orcid.org/0000-0002-7001-0226
-
Funding
Funding for this research was provided by:
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS103473)
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS103473)
HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS103473)
HHS | National Institutes of Health (R35CA209896)
HHS | National Institutes of Health (R01HL112626)
HHS | NIH | National Cancer Institute (P30CA013696)
- License Information
-
More Information
Article History
Received: 23 April 2024
Revised: 12 June 2024
Accepted: 1 July 2024
First Online: 27 August 2024
Disclosure and competing interests statement
: BRS is an inventor on patents and patent applications involving small molecule drug discovery, and the 3F3-FMA antibody, co-founded and serves as a consultant to Exarta Therapeutics, and ProJenX Inc., holds equity in Sonata Therapeutics, and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer & Feld LLP. PAS receives patent royalties from Guardant Health. Columbia University has filed a patent application on the microwell single-cell RNA-seq technology used in this study, and PAS is listed as a co-inventor.
